Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - glimepiride, quantity: 3 mg - tablet, uncoated - excipient ingredients: iron oxide yellow; magnesium stearate; lactose monohydrate; povidone; microcrystalline cellulose; sodium starch glycollate - as an adjunct to diet, exercise and weight loss, to lower the blood glucose in patients with non-insulin dependent (type 2) diabetes mellitus.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - glimepiride, quantity: 2 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; povidone; indigo carmine; magnesium stearate; sodium starch glycollate; iron oxide yellow; lactose monohydrate - as an adjunct to diet, exercise and weight loss, to lower the blood glucose in patients with non-insulin dependent (type 2) diabetes mellitus.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - glimepiride, quantity: 1 mg - tablet, uncoated - excipient ingredients: magnesium stearate; microcrystalline cellulose; povidone; lactose monohydrate; sodium starch glycollate; iron oxide red - as an adjunct to diet, exercise and weight loss, to lower the blood glucose in patients with non-insulin dependent (type 2) diabetes mellitus.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - metformin hydrochloride, quantity: 500 mg; glibenclamide, quantity: 5 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; povidone; magnesium stearate; microcrystalline cellulose; titanium dioxide; lactose monohydrate; hypromellose; quinoline yellow; iron oxide yellow; iron oxide red; macrogol 4000 - second line treatment of diabetes mellitus type ii in adult patients whose glycaemic control is inadequate after diet and exercise alone and where combined therapy with metformin and glibenclamide is appropriate.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - metformin hydrochloride, quantity: 500 mg; glibenclamide, quantity: 2.5 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; povidone; magnesium stearate; microcrystalline cellulose; titanium dioxide; lactose monohydrate; hypromellose; iron oxide yellow; iron oxide red; macrogol 4000; iron oxide black - second line treatment of diabetes mellitus type ii in adult patients whose glycaemic control is inadequate after diet and exercise alone and where combined therapy with metformin and glibenclamide is appropriate.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - metformin hydrochloride, quantity: 250 mg; glibenclamide, quantity: 1.25 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; povidone; magnesium stearate; microcrystalline cellulose; titanium dioxide; lactose monohydrate; hypromellose; purified talc; iron oxide yellow; macrogol 4000 - second line treatment of diabetes mellitus type ii in adult patients whose glycaemic control is inadequate after diet and exercise alone and where combined therapy with metformin and glibenclamide is appropriate.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - glimepiride, quantity: 4 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; magnesium stearate; sodium starch glycollate; povidone; microcrystalline cellulose; indigo carmine - dimirel is indicated as an adjunct to diet, exercise and weight loss, to lower the blood glucose in patients with non-insulin-dependent (type 2) diabetes mellitus.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - glimepiride, quantity: 3 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; iron oxide yellow; sodium starch glycollate; povidone; lactose monohydrate; magnesium stearate - dimirel is indicated as an adjunct to diet, exercise and weight loss, to lower the blood glucose in patients with non-insulin-dependent (type 2) diabetes mellitus.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - glimepiride, quantity: 2 mg - tablet, uncoated - excipient ingredients: iron oxide yellow; magnesium stearate; microcrystalline cellulose; povidone; lactose monohydrate; indigo carmine; sodium starch glycollate - dimirel is indicated as an adjunct to diet, exercise and weight loss, to lower the blood glucose in patients with non-insulin-dependent (type 2) diabetes mellitus.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - glimepiride, quantity: 1 mg - tablet, uncoated - excipient ingredients: sodium starch glycollate; lactose monohydrate; iron oxide red; magnesium stearate; povidone; microcrystalline cellulose - dimirel is indicated as an adjunct to diet, exercise and weight loss, to lower the blood glucose in patients with non-insulin-dependent (type 2) diabetes mellitus.